World Library  
Flag as Inappropriate
Email this Article

Natural killer T cell

Article Id: WHEBN0037793595
Reproduction Date:

Title: Natural killer T cell  
Author: World Heritage Encyclopedia
Language: English
Subject: Sulfatide, Gamma delta T cell, CD1D, CD49b, Zinc finger and BTB domain-containing protein 16
Collection: Human Cells, T Cells
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Natural killer T cell

Natural killer T (NKT) cells are a heterogeneous group of T cells that share properties of both T cells and natural killer cells. Many of these cells recognize the non-polymorphic CD1d molecule, an antigen-presenting molecule that binds self and foreign lipids and glycolipids. They constitute only approximately 0.1% of all peripheral blood T cells.[1] Natural killer T cells should not be confused with natural killer cells.

Contents

  • Nomenclature 1
  • Molecular characterization 2
  • Classification 3
  • iNKT cells 4
  • Function 5
  • Significance 6
  • See also 7
  • References 8
  • External links 9

Nomenclature

The term “NK T cells” was first used in mice to define a subset of T cells that expressed the natural killer (NK) cell-associated marker NK1.1 (CD161). It is now generally accepted that the term “NKT cells” refers to CD1d-restricted T cells, present in mice and humans, some of which coexpress a heavily biased, semi-invariant T-cell receptor and NK cell markers.[2] Natural killer T (NKT) cells should not be confused with natural killer cells.

Molecular characterization

NKT cells are a subset of T cells that coexpress an αβ T-cell receptor, but also express a variety of molecular markers that are typically associated with NK cells, such as mycobacterium, which causes tuberculosis.

NKT cells include both NK1.1+ and NK1.1-, as well as CD4+, CD4-, CD8+ and CD8- cells. Natural killer T cells can share other features with NK cells, as well, such as CD16 and CD56 expression and granzyme production.[3][4]

Invariant natural killer T (iNKT) cells express high levels of and are dependent on the transcriptional regulator promyelocytic leukemia zinc finger for their development.[5][6]

Classification

Classification of natural killer T cells into three groups has been proposed:[2]
Type 1 NKT Type 2 NKT NKT-like
Other names classical NKT
invariant NKT (iNKT)
Vα14i NKT (mouse)
Vα24i NKT (human)
non-classical NKT
diverse NKT
NK1.1+ T cells
CD3+ CD56+ T cells
Restriction CD1d CD1d MHC, other?
α-GalCer
reactivity
+ - -
T-cell-receptor repertoire Vα14-Jα18:
Vβ8.2, 7, 2 (mouse)
Vα24-Jα18:
Vβ11 (human)
diverse diverse

iNKT cells

The best-known subset of CD1d-dependent NKT cells expresses an invariant T-cell receptor α chain. These are referred to as type I or invariant NKT cells (iNKT) cells. These cells are conserved between humans and mice and are implicated in many immunological processes. Absence of microbe exposure in early development led to increased iNKT cells and immune morbidity in a mouse model.[7]

Function

Upon activation, NKT cells are able to produce large quantities of interferon-gamma, IL-4, and granulocyte-macrophage colony-stimulating factor, as well as multiple other cytokines and chemokines (such as IL-2, Interleukin-13, Interleukin-17, Interleukin-21, and TNF-alpha).

Significance

NKT cells seem to be essential for several aspects of immunity because their dysfunction or deficiency has been shown to lead to the development of autoimmune diseases (such as diabetes or atherosclerosis) and cancers. NKT cells have recently been implicated in the disease progression of human asthma.[8]

The clinical potential of NKT cells lies in the rapid release of cytokines (such as IL-2, IFN-gamma, TNF-alpha, and IL-4) that promote or suppress different immune responses.

See also

References

  1. ^ Jerud, ES; Bricard G; Porcelli SA (2006). "Natural Killer T cells: Roles in Tumor Immunosurveillance and Tolerance". Transfus. Med. Hemother. 33 (1): 18–36.  
  2. ^ a b Godfrey, DI; MacDonald HR; Kronenberg M; Smyth MJ; Van Kaer L (2004). "NKT cells: what’s in a name?". Nat. Rev. Immunol. 4 (3): 231–7.  
  3. ^ Van der Vliet, HJ; Nishi N; Koezuka Y; Peyrat MA; Von Blomberg BM; Van den Eertwegh AJ; Pinedo HM; Giaccone G; Scheper RJ (1999). T cells"+ Vb11+"Effects of alphagalactosylceramide (KRN7000), interleukin-12 and interleukin-7 on phenotype and cytokine profile of human Va24. Immunology 98 (4): 557–563.  
  4. ^ Vivier, E; Anfossi N (2004). "Inhibitory NK-cell receptors on T cells. Witness of the past, actors of the future.". Nat Rev Immunol 4 (3): 190–198.  
  5. ^ Kovalovsky D, Uche OU, et al. (Sep 2008). "The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions.". Nature Immunology 9 (9): 1055–64.  
  6. ^ Savage AK, Constantinides MG, et al. (Sep 2008). "The transcription factor PLZF directs the effector program of the NKT cell lineage.". Immunity 29 (3): 391–403.  
  7. ^ Olszak, et al. (2012). "Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function". Science 336 (6080): 489–93.  
  8. ^ Cromie, William J. Researchers uncover cause of asthma Harvard University Gazette, March 16, 2006.

External links

  • NKT cell Journal Screening
  • Nature glossary on murine NKT cells
  • Nature Reviews Web Focus on regulatory lymphocytes
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.